VCAN and breast cancer: These results revealed that a high VCAN-AS1 level was related to worse survival in BC patients (p = 0.0484, Figure 1(f)), while a low miR-106a-5p level was associated with worse survival in BC patients (p = 0.036, Figure 1(g)).